← Open Payments lookup

JESSE BACH: Open Payments

NPI 1144849985 · MINNEAPOLIS, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$3,140 in 191 payments from 15 companies in 2025. Trend: 2023 $22 · 2024 $639 · 2025 $3,140

Food & beverage: $3,140
CompanyPaymentsAmount
Salix Pharmaceuticals, a division of Bausch Health US, LLC46$442
ABBVIE INC.25$387
QOL Medical, LLC11$296
Janssen Biotech, Inc.16$292
Ardelyx, Inc.15$287
Celltrion USA Inc.16$268
Takeda Pharmaceuticals U.S.A., Inc.13$248
GENZYME CORPORATION7$194
PFIZER INC.17$178
Ipsen Biopharmaceuticals, Inc7$169

Products named: XIFAXAN, Sucraid, TREMFYA, IBSRELA, VEGZELMA, DUPIXENT, VELSIPITY, RINVOQ.

Industry payments across MN — which companies pay providers there.